期刊文献+

^(18)F-FDG PET/CT在诊断浸润性乳腺癌和淋巴结转移中的价值 被引量:31

^(18)F-FDG PET/CT in diagnosis of invasive breast cancer and lymph node metastasis
下载PDF
导出
摘要 目的评估氟-18标记的2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描(18F-FDG PET/CT)在诊断乳腺癌和腋窝淋巴结(ALN)转移中的价值。方法回顾性分析88例浸润性乳腺癌患者病例资料,所有患者均行18F-FDG PET/CT、钼靶X线和超声检查,40例患者行磁共振成像(MRI)检查,将诊断结果与术后病理结果进行比较。结果 88例病理学检查证实浸润性乳腺癌患者中18F-FDG PET/CT检查阳性75例(85%),阴性13例(15%)。18F-FDG PET/CT、钼靶X线、超声检查、钼靶X线结合超声检查和MRI诊断敏感度分别为85%(75/88)、85%(75/88)、92%(81/88)、97%(85/88)和95%(38/40)。与钼靶X线、超声检查和MRI比较,18F-FDG PET/CT诊断原发性乳腺癌的敏感度差异无统计学意义(P>0.05),钼靶X线检查结合超声的敏感度高于18F-FDG PET/CT(P<0.05)。18F-FDG PET/CT诊断原发性乳腺癌的敏感度与肿瘤分期和大小相关(P<0.05)。以最大标准摄取值(SUVmax)1.5为阳性判断标准,18F-FDG PET/CT诊断乳腺癌ALN转移的敏感度、特异度、准确度、阳性预测值和阴性预测值分别为34.1%(8/21)、84%(56/67)、72%(64/88)、42%(8/19)和81%(56/69),假阴性和假阳性率分别为19%(13/69)和57%(11/19)。结论 18F-FDG PET/CT诊断乳腺癌敏感度并不优于钼靶X线、超声和MRI检查,在乳腺癌ALN转移诊断中的价值有限。钼靶X线结合超声检查敏感度高,是诊断乳腺癌的首选方法。 Objective To evaluate the value of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography(18F-FDG PET/CT) in the diagnosis of primary breast cancer and axillary lymph node(ALN) metastasis.Methods The clinical data of 88 patients with invasive breast cancer were retrospectively analysed.All patients underwent 18F-FDG PET/CT scanning,mammography and ultrasonography examinations,and 40 patients received magnetic resonance imaging(MRI).The diagnostic results of 18F-FDG PET/CT were compared with postoperative pathological findings.Results In 88 patients with pathologically confirmed breast cancer,18F-FDG PET/CT was positive in 75(85%) patients and negative in 13(15%) patients.The values of sensitivity of 18F-FDG PET/CT,mammography,ultrasonography,mammography combined with ultrasonography,and MRI were 85%(75/88),85%(75/88),92%(81/88),97%(85/88) and 95%(38/40) respectively.The sensitivity of mammography combined with ultrasonography was significantly higher than that of 18F-FDG PET/CT(P〈0.05),while there was no significant difference between 18F-FDG PET/CT and mammography,ultrasonography and MRI(P〉0.05).The sensitivity of 18F-FDG PET/CT in diagnosis of primary breast cancer was significantly related to tumor staging and size(P〈0.05).With maximum standard uptake value(SUVmax) cutoff at 1.5,the sensitivity,specificity,accuracy,positive predictive value and negative predictive value of 18F-FDG PET/CT in diagnosis of ALN metastasis were 34.1%(8/21),84%(56/67),72%(64/88),42%(8/19) and 81%(56/69) respectively,and the false negative rate and false positive rate were 19%(13/69) and 57%(11/19) respectively.Conclusion 18F-FDG PET/CT is not superior to mammography,ultrasonography and MRI in diagnosis of breast cancer,which has limited value in determination of ALN metastasis.Mammography combined with ultrasonography has higher sensitivity and is the first choice for diagnosis of breast cancer.
作者 唐立岷 马超
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第6期761-765,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30700185)~~
关键词 乳腺癌 18F-FDG PET/CT 钼靶X线检查 超声检查 腋窝淋巴结 breast cancer; 18F-FDG PET/CT; mammography; ultrasonography; axillary lymph node
  • 相关文献

参考文献28

  • 1Cabrera Villegas A, Garcia Velloso MJ, GOmez Cenzano C. Positron emission tomography (PET) in clinical oncology[ Part III][ J]. Rev Esp Med Nucl, 2002, 21(4) : 304 -320.
  • 2Esca|ona S, Blasco JA, Reza MM, et al. A systematic review of FDG-PET in breast cancer[J]. Med Oncol, 2010, 27(1) : lid- - 129.
  • 3Yutani K, Shiba E, Kusuoka H, et al. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis [ J ]. J Comput Assist Tomogr, 2000, 24 (2): 274-280.
  • 4Ueda S, Tsuda H, Asakawa H, et al. Utility of lgF-fluoro-deoxy- glucose emission tomography/computed tomography fusion imaging (18 F-FDG PET/CT) in combination with uhrasonography for axiliary staging in primary breast cancer[ J]. BMC Cancer, 2008, 8: 165.
  • 5Schirrmeister H, Ktihn T, Guhlmann A, et al. F|uorine-18 2-deoxy- 2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures [ J]. Eur J Nucl Med, 2001, 28(3) : 351 -358.
  • 6Lovrics PJ, Chen V, Coates G, et al. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer[J]. Ann Surg Oncol, 2004, 11(9) : 846 - 853.
  • 7Taira N, Ohsumi S, Takabatake D, et al. Determination of indica- tion for sentinel lymph node biopsy ,in clinical node-negative breast cancer using preoperative 18F-fluorodeoxygluq'ose positron emission tomogral,,omputed tomography fusion intaging [J]. Jpn J Clin Oncol. 2009. 39(1) : 16 -21.
  • 8Waher W, Scheidhauer K, Scharl A, et al. Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions[J]. Eur Radiol, 2003, 13(7) : 1651 - 1656.
  • 9Heinsich M, Gallowitsch HJ, Mikosch P, et al. Comparison of FDG-PET and dynamic contrast-enhanced RM in the evaluation of suggestive breast lesions [ J ]. Breast, 2003, 12 ( 1 ) : 17 - 22.
  • 10Rieber A, Schirrmeister H, Gabelmann A, et al. Pre-operative stag- ing of invasive breast cancer with MR mammography and/or FDG-PET: boon or bunk? [J] Br J Radiol, 2002, 75(898) : 789 - 795.

二级参考文献14

  • 1Lyshehik A Higashi T Asato R 王延安.声弹性成像诊断淋巴结转移癌的初步经验[J].中国口腔颌面外科杂志,2007,5(3):224-224. 被引量:55
  • 2ZytoonAA, Murakamib K, EbKholy MR, et al. Breast cancer with low FDG uptake: characterization by means of dualtime point FDGPET/CT [J]. Eur J Radiol, 2009, 70 (3): 530 -538.
  • 3GrassettoaG, Fornasiero A, Otellob D, et al. taF-FDG- PET/CT in patients with breast cancer and rising Ca 153 with negative conventional imaging= A multicentre study [J]. Eur J Radiol, 2010[Epub ahead of print].
  • 4Gerwin PS, Andrea BM, Alexander H, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole body MR1 at 1.5 and 3 T compared to FDG PET CT[J]. EurJ Radiol, 2008, 65 (1): 47-58.
  • 5Groheux D, Moretti JL, Baillel G, et al. Effect of (18)F- FDG PET/CT imaging in patients with clinical stage Ⅱ and Ⅲ breast cancer E J~. Int J Radiat Oncol Biol Phys, 2008, 71(3):695 -704.
  • 6Poeppel TD, Krause BJ, Heusner TA, et al. PET/CT for the staging and follow up of patients with malignancies[J]. Eur J Radiol, 2009, 70(3): 382-392.
  • 7de Bresser J, de Vos B, van der Ent F, et al. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: A systematic review[J]. Eur J SurgOncol, 2010, 36 (2): 114-119.
  • 8Kuhl C, Kuhn W, Braun M, et al. Pre-operative staging o{ breast cancer with breast MRI: One step forward, two steps back? [J]. Breast, 2007, 16(Suppl 2):S34-S44.
  • 9Ueguchi T, Yamada S, Mihara N, et al. Breast diffusion- weighted MRI: Comparison of tetrahedral versus orthogonal diffusion sensitization for detection and localization of mass lesions[J]. J MagnReson Imaging, 20ll, 33(6): 1375 -1381.
  • 10Yau EJ, Gutierrez RL, Demartini WB, et al. The utility of breast MRI as a problem solving tool [J]. Breast J, 2011,17(3): 273-280.

共引文献14

同被引文献238

引证文献31

二级引证文献220

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部